These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24736068)

  • 1. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on high-resolution images for the possibility of future change.
    Tamura M; Shimizu Y; Yamamoto T; Yoshikawa J; Hashizume Y
    J Thorac Oncol; 2014 Apr; 9(4):469-72. PubMed ID: 24736068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
    Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
    Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-dimensional mean computed tomography value evaluation of ground-glass opacity on high-resolution images.
    Kitami A; Kamio Y; Hayashi S; Suzuki K; Uematsu S; Gen R; Suzuki T; Kadokura M
    Gen Thorac Cardiovasc Surg; 2012 Jul; 60(7):425-30. PubMed ID: 22653422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Retrospective Study of Mean Computed Tomography Value to Predict 
the Tumor Invasiveness in AAH and Clinical Stage Ia Lung Cancer].
    Wu H; Liu C; Xu M; Xiong R; Xu G; Li C; Xie M
    Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):190-196. PubMed ID: 29587938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.
    Li F; Sone S; Abe H; Macmahon H; Doi K
    Radiology; 2004 Dec; 233(3):793-8. PubMed ID: 15498895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Dimensional Ground Glass Opacity Ratio in CT Images Can Predict Tumor Invasiveness of Stage IA Lung Cancer.
    Yu WS; Hong SR; Lee JG; Lee JS; Jung HS; Kim DJ; Chung KY; Lee CY
    Yonsei Med J; 2016 Sep; 57(5):1131-8. PubMed ID: 27401643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change.
    Bak SH; Lee HY; Kim JH; Um SW; Kwon OJ; Han J; Kim HK; Kim J; Lee KS
    Chest; 2016 Jan; 149(1):180-91. PubMed ID: 26313232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.
    Aoki T; Hanamiya M; Uramoto H; Hisaoka M; Yamashita Y; Korogi Y
    Radiology; 2012 Aug; 264(2):590-6. PubMed ID: 22653188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
    Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
    Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation.
    Lu CH; Hsiao CH; Chang YC; Lee JM; Shih JY; Wu LA; Yu CJ; Liu HM; Shih TT; Yang PC
    J Thorac Oncol; 2012 Jan; 7(1):143-50. PubMed ID: 22124475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary ground-glass opacity (GGO) lesions-large size and a history of lung cancer are risk factors for growth.
    Hiramatsu M; Inagaki T; Inagaki T; Matsui Y; Satoh Y; Okumura S; Ishikawa Y; Miyaoka E; Nakagawa K
    J Thorac Oncol; 2008 Nov; 3(11):1245-50. PubMed ID: 18978558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
    Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
    J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
    Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer.
    Kim HK; Choi YS; Kim K; Shim YM; Jeong SY; Lee KS; Kwon OJ; Kim J
    J Thorac Oncol; 2009 Oct; 4(10):1242-6. PubMed ID: 19687762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.